Not applicableStudy completedNCT03903237What this trial is testingHerpes Zoster: Risk Factors, Complications and Special SituationsWho this might be right forHerpes Zoster University Hospital, Basel, Switzerland 355
Early research (Phase 1)Study completedNCT01262300What this trial is testingVitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care ResidentsWho this might be right forImmunosenescenceShingles University of Colorado, Denver 33
Large-scale testing (Phase 3)Study completedNCT01165177What this trial is testingStudy to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and OlderWho this might be right forHerpes Zoster GlaxoSmithKline 16,165
Post-approval studies (Phase 4)Not Yet RecruitingNCT07818356What this trial is testingComparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled TrialWho this might be right forVaccineVaricella-zoster VirusMultiple Sclerosis+1 more University Hospital, Toulouse 160
Testing effectiveness (Phase 2)Ended earlyNCT00352651What this trial is testingStudy to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With PlaceboWho this might be right forHerpes ZosterPostherpetic Neuralgia University of California, San Francisco 34
Post-approval studies (Phase 4)Enrolling By InvitationNCT06484686What this trial is testingAn Immunity Persistence Study of Booster Dose of Live Attenuated Varicella VaccineWho this might be right forVaricella Sinovac (Dalian) Vaccine Technology Co., Ltd. 414
Large-scale testing (Phase 3)Study completedNCT00092391What this trial is testingAn Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)Who this might be right forMeaslesMumpsRubella+1 more Merck Sharp & Dohme LLC 1,997
Testing effectiveness (Phase 2)Looking for participantsNCT05422508What this trial is testingEvaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella VaccinationWho this might be right forVaricella Green Cross Corporation 230
Testing effectiveness (Phase 2)Ended earlyNCT00258726What this trial is testingImmune Responses to Two Dose Varivax +/- MMR-IIWho this might be right forMeaslesMumpsRubella+1 more National Institute of Allergy and Infectious Diseases (NIAID) 105
Testing effectiveness (Phase 2)Study completedNCT00001344What this trial is testingDextromethorphan Versus Placebo for Neuropathic PainWho this might be right forDiabetic NeuropathiesHerpes ZosterNeuralgia National Institute of Dental and Craniofacial Research (NIDCR) 129
Early research (Phase 1)Active Not RecruitingNCT05636436What this trial is testingSafety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and AboveWho this might be right forHerpes Zoster MAXVAX Biotechnology Limited Liability Company 132
Not applicableUnknownNCT01166295What this trial is testingDevelopment of a Bedside Pain Assessment Kit for Postherpetic NeuralgiaWho this might be right forNeuralgiaHerpes Zoster Analgesic Solutions 12
Early research (Phase 1)Study completedNCT05991427What this trial is testingEvaluate the Safety and Immunogenicity of ChAdOx1-VZV in Healthy Adults Aged 50-65 YearsWho this might be right forHerpes Zoster CanSino Biologics Inc. 65
Large-scale testing (Phase 3)UnknownNCT01102101What this trial is testingEffect of Opioids in Neuropathic Pain in Postherpetic PatientsWho this might be right forNeuralgia, Postherpetic Medical University of Vienna 30
Testing effectiveness (Phase 2)Study completedNCT00802464What this trial is testingImmunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 YearsWho this might be right forHerpes Zoster GlaxoSmithKline 410
Large-scale testing (Phase 3)Study completedNCT00127023What this trial is testingImmunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesWho this might be right forMumpsVaricellaRubella+1 more GlaxoSmithKline 944
Not applicableStudy completedNCT01331161What this trial is testingSystems Biology of Zoster Vaccine (ZOSTAVAX®) in Young and ElderlyWho this might be right forShingles Emory University 77
Large-scale testing (Phase 3)Study completedNCT02723773What this trial is testingA Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older AdultsWho this might be right forHerpes ZosterHerpes Zoster Vaccine GlaxoSmithKline 7,539
Post-approval studies (Phase 4)Study completedNCT01556451What this trial is testingZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)Who this might be right forHerpes ZosterShingles Merck Sharp & Dohme LLC 180
Testing effectiveness (Phase 2)Study completedNCT00546819What this trial is testingZOSTAVAX™ in Patients on Chronic/Maintenance Corticosteroids (V211-017) (COMPLETED)Who this might be right forHerpes Zoster Merck Sharp & Dohme LLC 309